Moolec Science (NASDAQ:MLEC) & RF Acquisition Corp II (NASDAQ:RFAI) Head-To-Head Review

Moolec Science (NASDAQ:MLEC) and RF Acquisition Corp II (NASDAQ:RFAI) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

Earnings and Valuation

This table compares Moolec Science and RF Acquisition Corp II”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Moolec Science	$5.63 million	6.08	-$7.31 million	($0.20)	-4.45
RF Acquisition Corp II	N/A	N/A	N/A	N/A	N/A

RF Acquisition Corp II has lower revenue, but higher earnings than Moolec Science.

Profitability

This table compares Moolec Science and RF Acquisition Corp II’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Moolec Science	-129.97%	-97.95%	-27.91%
RF Acquisition Corp II	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Moolec Science and RF Acquisition Corp II, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Moolec Science	0	0	1	0	3.00
RF Acquisition Corp II	0	0	0	0	0.00

Moolec Science currently has a consensus price target of $6.00, indicating a potential upside of 574.23%. Given Moolec Science’s stronger consensus rating and higher probable upside, research analysts clearly believe Moolec Science is more favorable than RF Acquisition Corp II.

Institutional and Insider Ownership

0.1% of Moolec Science shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Moolec Science beats RF Acquisition Corp II on 6 of the 9 factors compared between the two stocks.

About Moolec Science

Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

About RF Acquisition Corp II

We are a blank check company incorporated on February 5, 2024, as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, which we refer to throughout this prospectus as our “business combination” or “initial business combination,” with one or more businesses or entities, which we refer to throughout this prospectus as a “target business” or “target businesses”. Although we are not limited to target businesses in any specific industry or geographic location, we intend to initially focus our search on target businesses in Asia within the deep technology sector, including artificial intelligence, quantum computing, and biotechnology. However, we will not consummate our initial business combination with an entity or business with China operations consolidated through a variable interest entity (“VIE”) structure. The ownership of our securities by U.S. investors may limit the pool of acquisition candidates we may acquire in China due to the relevant PRC laws and regulations against foreign ownership of and investment in certain assets and industries, known as restricted industries. The approval of PRC regulatory agencies may be required in connection with our initial business combination, and if required, we may not be able to obtain such approval. We have generated no revenues to date and we do not expect that we will generate operating revenues until, at the earliest, we consummate our initial business combination. Our management team is continuously made aware of potential business opportunities, one or more of which we may desire to pursue for an initial business combination. However, we have not selected any specific target business and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any target business with respect to an initial business combination with us. We believe that our management team’s strong background, contacts and sources and geographic reach will provide us with high quality acquisition opportunities and possibly complementary follow-on business arrangements. These contacts and sources include industry executives, private owners, private equity funds, family offices, commercial and investment bankers, lawyers and other financial sector service providers and participants. Our executive office is located at 111 Somerset, #05-07, Singapore.